Pfizer wins right to challenge Prempro damages award; Asthma market flat until … – FiercePharma

Pfizer wins right to challenge Prempro damages award; Asthma market flat until
FiercePharma
Item > The asthma drug market will remain flat at around $14.4 billion through 2020, thanks in part to generic rivals for Merck's ($MRK)Singulair, Decision Resources concludes. Release > Teva Pharmaceutical Industries ($TEVA) won an appeals court's

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.